Eduard Kelenchuk, a Senior Officer, disposed of 100,000 Subordinate Voting Shares on a direct ownership basis at a price of $10.170 through a private transaction on September 12th, 2019. This represents a $1,017,000 divestment of the company's shares and an account share holdings change of -52.6%.
Curaleaf Holdings is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Curaleaf Holdings Inc, formerly known as Lead Ventures Inc, is a Canada-based vertically integrated cannabis operator in the United States. The Company is focused on research and development capabilities to distribute cannabis products. The Company operates in 12 states with 48 dispensaries, 14 cultivation sites and 13 processing sites. It provides service, selection, and accessibility across the medical and adult-use markets, as well as the cannabidiol (CBD) category through its Curaleaf Hemp brand. It owns and operates a number of dispensaries, cultivation sites and processing sites with a focus on limited license states, including Florida, Massachusetts, New Jersey and New York.
No Comments